ProFunds Pharmaceuticals UltraSector Fund Service Class (PHPSX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
18.25
-0.25 (-1.35%)
Jun 27, 2025, 4:00 PM EDT
-3.29% (1Y)
| Fund Assets | 10.07M |
| Expense Ratio | 2.78% |
| Min. Investment | $5,000 |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 18.50 |
| YTD Return | -10.93% |
| 1-Year Return | -3.29% |
| 5-Year Return | 13.09% |
| 52-Week Low | 15.87 |
| 52-Week High | 24.50 |
| Beta (5Y) | 0.88 |
| Holdings | 52 |
| Inception Date | Jun 28, 2000 |
About PHPSX
The ProFunds Pharmaceuticals UltraSector Fund Service Class (PHPSX) seeks to measure the performance of certain companies in the pharmaceuticals sector of the U.S. equity market.
Category Trading--Leveraged Equity
Stock Exchange NASDAQ
Ticker Symbol PHPSX
Share Class Service Class
Index S&P 500 TR
Performance
PHPSX had a total return of -3.29% in the past year, including dividends. Since the fund's inception, the average annual return has been 0.80%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| PHPIX | Investor Class | 1.78% |
Top 10 Holdings
33.79% of assets| Name | Symbol | Weight |
|---|---|---|
| SOCIETE' GENERALE 4.23 , 5/01/2025 | n/a | 5.90% |
| HSBC SECURITIES (USA), INC. 4.28 , 5/01/2025 | n/a | 5.61% |
| Corcept Therapeutics Incorporated | CORT | 3.52% |
| Eli Lilly and Company | LLY | 2.95% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.83% |
| Royalty Pharma plc | RPRX | 2.69% |
| Zoetis Inc. | ZTS | 2.61% |
| Johnson & Johnson | JNJ | 2.59% |
| Pfizer Inc. | PFE | 2.56% |
| Axsome Therapeutics, Inc. | AXSM | 2.53% |